Khan Arif O, Bolz Hanno J, Bergmann Carsten
Division of Pediatric Ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Center of Human Genetics, Bioscientia, Ingelheim, Germany; Institute of Human Genetics, University of Cologne, Cologne, Germany.
J AAPOS. 2014 Apr;18(2):134-9. doi: 10.1016/j.jaapos.2013.11.012.
Autosomal dominant mutation of the FBN1 gene (fibrillin-1) results in a spectrum of disease (type 1 fibrillopathies) ranging from Marfan syndrome with lens subluxation and cardiovascular complications to milder connective tissues phenotypes. The likelihood of FBN1 mutation in children referred to ophthalmologists because of lens subluxation is unclear. We report the results of routine FBN1 sequencing for children from inbred families referred with nontraumatic lens subluxation without cataract or vitreoretinal degeneration.
Medical records of such patients from 2009 to 2012 were retrospectively reviewed.
Eight identified probands (3-11 years old; 4 boys) from consanguineous and/or endogamous Saudi Arabian families all harbored FBN1 mutation--7 autosomal dominant and 1 autosomal recessive (homozygous). Four mutations were novel. One child had a family history for lens subluxation. Seven had facial and/or skeletal features suggestive of type 1 fibrillinopathy. The parents of the autosomal recessive case were confirmed to be heterozygous carriers without lens subluxation or other clinical signs of type 1 fibrillinopathy.
Autosomal dominant type 1 fibrillinopathy was the major cause for lens subluxation in this cohort despite the fact that families were inbred and thus at higher risk for recessive disease. This highlights the frequency of new mutations in the gene and has important implications for genetic counseling and systemic assessment. The autosomal recessive case represents the fourth such case reported to date. Her heterozygous parents were unaffected carriers, suggesting that some FBN1 mutations can act as hypomorphic alleles rather than exhibiting the dominant negative effect typically attributed to FBN1 mutations.
FBN1基因(原纤蛋白-1)的常染色体显性突变会导致一系列疾病(1型纤维病),范围从伴有晶状体半脱位和心血管并发症的马凡综合征到较轻的结缔组织表型。因晶状体半脱位而转诊至眼科医生处的儿童发生FBN1突变的可能性尚不清楚。我们报告了对来自近亲家庭、因非创伤性晶状体半脱位而转诊且无白内障或玻璃体视网膜变性的儿童进行FBN1常规测序的结果。
对2009年至2012年此类患者的病历进行回顾性审查。
8名已确定的先证者(年龄3至11岁;4名男孩)来自近亲结婚和/或同族通婚的沙特阿拉伯家庭,均携带FBN1突变——7个常染色体显性突变和1个常染色体隐性突变(纯合子)。4个突变是新发现的。1名儿童有晶状体半脱位家族史。7名儿童有面部和/或骨骼特征提示1型纤维病。常染色体隐性病例的父母被证实为杂合子携带者,无晶状体半脱位或1型纤维病的其他临床体征。
在这一队列中,常染色体显性1型纤维病是晶状体半脱位的主要原因,尽管这些家庭是近亲结婚,因此患隐性疾病的风险更高。这突出了该基因新突变的频率,对遗传咨询和全身评估具有重要意义。该常染色体隐性病例是迄今为止报道的第四例此类病例。她的杂合子父母未受影响,表明一些FBN1突变可作为亚效等位基因,而非表现出通常归因于FBN1突变的显性负效应。